Endymed Financials
| ENDY Stock | 297.90 2.00 0.67% |
Endymed |
Understanding current and past Endymed Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Endymed's financial statements are interrelated, with each one affecting the others. For example, an increase in Endymed's assets may result in an increase in income on the income statement.
Please note, the presentation of Endymed's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Endymed's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Endymed's management manipulating its earnings.
Endymed Stock Summary
Endymed competes with Nextcom, Palram, Bio View, Sofwave Medical, and Automatic Bank. Endymed Ltd, a medical technology company, designs, develops, and commercializes energy based medical aesthetic treatment systems for the professional and consumer markets worldwide. Endymed Ltd was founded in 2007 and is based in New York, New York. ENDYMED LTD operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange.| Instrument | Israel Stock View All |
| Exchange | Tel Aviv Stock Exchange |
| ISIN | IL0011010217 |
| Business Address | 4400 Route 9 |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.endymed.com |
| Phone | 855 363 9633 |
You should never invest in Endymed without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Endymed Stock, because this is throwing your money away. Analyzing the key information contained in Endymed's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Endymed Key Financial Ratios
Endymed's financial ratios allow both analysts and investors to convert raw data from Endymed's financial statements into concise, actionable information that can be used to evaluate the performance of Endymed over time and compare it to other companies across industries.| Return On Equity | 0.21 | |||
| Return On Asset | 0.0385 | |||
| Number Of Employees | 41 | |||
| Beta | -0.0864 | |||
| Z Score | 46.6 |
Endymed Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Endymed's current stock value. Our valuation model uses many indicators to compare Endymed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Endymed competition to find correlations between indicators driving Endymed's intrinsic value. More Info.Endymed is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.18 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Endymed is roughly 5.57 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Endymed by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Endymed's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Endymed Systematic Risk
Endymed's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Endymed volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was four with a total number of output elements of fifty-seven. The Beta measures systematic risk based on how returns on Endymed correlated with the market. If Beta is less than 0 Endymed generally moves in the opposite direction as compared to the market. If Endymed Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Endymed is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Endymed is generally in the same direction as the market. If Beta > 1 Endymed moves generally in the same direction as, but more than the movement of the benchmark.
Endymed November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Endymed help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Endymed. We use our internally-developed statistical techniques to arrive at the intrinsic value of Endymed based on widely used predictive technical indicators. In general, we focus on analyzing Endymed Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Endymed's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.31 | |||
| Information Ratio | 0.0024 | |||
| Maximum Drawdown | 47.62 | |||
| Value At Risk | (6.46) | |||
| Potential Upside | 4.1 |
Complementary Tools for Endymed Stock analysis
When running Endymed's price analysis, check to measure Endymed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Endymed is operating at the current time. Most of Endymed's value examination focuses on studying past and present price action to predict the probability of Endymed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Endymed's price. Additionally, you may evaluate how the addition of Endymed to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |